CEL-SCI CVM Stock
CEL-SCI Price Chart
CEL-SCI CVM Financial and Trading Overview
CEL-SCI stock price | 0.22 USD |
Previous Close | 2.42 USD |
Open | 2.42 USD |
Bid | 2.31 USD x 800 |
Ask | 0 USD x 1200 |
Day's Range | 2.4 - 2.46 USD |
52 Week Range | 1.86 - 5.42 USD |
Volume | 30.74K USD |
Avg. Volume | 160.31K USD |
Market Cap | 107.76M USD |
Beta (5Y Monthly) | 1.63345 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.48 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | August 28, 1996 |
1y Target Est | 10.5 USD |
CVM Valuation Measures
Enterprise Value | 112.59M USD |
Trailing P/E | N/A |
Forward P/E | -5.0208335 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 5.2391305 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -3.809 |
Trading Information
CEL-SCI Stock Price History
Beta (5Y Monthly) | 1.63345 |
52-Week Change | -38.67% |
S&P500 52-Week Change | 20.43% |
52 Week High | 5.42 USD |
52 Week Low | 1.86 USD |
50-Day Moving Average | 2.45 USD |
200-Day Moving Average | 2.81 USD |
CVM Share Statistics
Avg. Volume (3 month) | 160.31K USD |
Avg. Daily Volume (10-Days) | 68.35K USD |
Shares Outstanding | 44.71M |
Float | 43.01M |
Short Ratio | 39.02 |
% Held by Insiders | 3.88% |
% Held by Institutions | 13.78% |
Shares Short | 4.97M |
Short % of Float | 11.55% |
Short % of Shares Outstanding | 11.10% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | September 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | September 30, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -40.90% |
Return on Equity (ttm) | -108.43% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | -25355346 USD |
EBITDA | -29558648 USD |
Net Income Avi to Common (ttm) | -35391576 USD |
Diluted EPS (ttm) | -0.8 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 10.08M USD |
Total Cash Per Share (mrq) | 0.23 USD |
Total Debt (mrq) | 14.46M USD |
Total Debt/Equity (mrq) | 71.77 USD |
Current Ratio (mrq) | 2.367 |
Book Value Per Share (mrq) | 0.46 |
Cash Flow Statement
Operating Cash Flow (ttm) | -22841164 USD |
Levered Free Cash Flow (ttm) | -7645016 USD |
Profile of CEL-SCI
Country | United States |
State | VA |
City | Vienna |
Address | 8229 Boone Boulevard |
ZIP | 22182 |
Phone | 703 506 9460 |
Website | https://cel-sci.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research, development, and manufacturing of immune systems for the treatment of cancer and other diseases. The company's lead investigational immunotherapy is Multikine, a Leukocyte Interleukin injection, which has completed a pivotal Phase 3 clinical trial for patients, who are diagnosed with locally advanced primary squamous cell carcinoma of the head and neck. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer. In addition, the company is developing CEL-2000 and CEL-4000 which are LEAPS based product candidates for the treatment of rheumatoid arthritis disease. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia.
Q&A For CEL-SCI Stock
What is a current CVM stock price?
CEL-SCI CVM stock price today per share is 0.22 USD.
How to purchase CEL-SCI stock?
You can buy CVM shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CEL-SCI?
The stock symbol or ticker of CEL-SCI is CVM.
Which industry does the CEL-SCI company belong to?
The CEL-SCI industry is Biotechnology.
How many shares does CEL-SCI have in circulation?
The max supply of CEL-SCI shares is 84.12M.
What is CEL-SCI Price to Earnings Ratio (PE Ratio)?
CEL-SCI PE Ratio is now.
What was CEL-SCI earnings per share over the trailing 12 months (TTM)?
CEL-SCI EPS is -0.48 USD over the trailing 12 months.
Which sector does the CEL-SCI company belong to?
The CEL-SCI sector is Healthcare.
CEL-SCI CVM included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE AMEX COMPOSITE INDEX XAX | 4607.95 USD — |
-6.27
|
— — | 4557.87 USD — | 4916.25 USD — | — - | — — |
- {{ link.label }} {{link}}